NeoGenomics, Inc. Stock News

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announced the appointment of Felicia Williams to its Board of Directors.

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in a fireside chat at the Piper Sandler 36th Annual Healthcare Conference in New York City.

NeoGenomics, Inc. (NASDAQ:NEO ) Q3 2024 Earnings Conference Call November 5, 2024 8:30 AM ET Company Participants Kendra Sweeney - Vice President, Investor Relations and ESG Chris Smith - Chief Executive Officer Jeffrey Sherman - Chief Financial Officer Warren Stone - Chief Commercial Officer Kareem Saad - Head, Strategy and Transformation Andrew Lukowiak - Chief Innovation Officer Nate Montgom...

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics has received conditional approval from the NYSDOH for its Neo Comprehensive Solid Tumor assay and NeoTYPE DNA & RNA Lung test.

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will report its third quarter 2024 financial results prior to the open of the U.S. financial markets on Tuesday, Nov. 5, 2024.

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics' AML Express is an NGS assay designed to provide rapid, comprehensive genetic profiling for patients with acute myeloid leukemia.

Shares of NeoGenomics Inc (NEO, Financial) surged 3.95% in mid-day trading on Oct 2. The stock reached an intraday high of $14.36, before settling at $14.36, up from its previous close of $13.81.

FT. MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics announces new RaDaR technology and resolution of RaDaR 1.0 litigation.